Coeptis Therapeutics Inc. is a forward-thinking biopharmaceutical company based in Wexford, Pennsylvania, specializing in the development and commercialization of innovative cancer therapies that blend branded and generic pharmaceuticals with advanced cell therapy platforms. With a strong commitment to addressing significant unmet medical needs in oncology, Coeptis aims to enhance treatment outcomes and improve the quality of life for patients. The company's strategic emphasis on rigorous research and development positions it as a key player in the competitive cancer therapeutics market, highlighting its potential to deliver transformative solutions within the biopharmaceutical sector. Show more

Location: 105 BRADFORD ROAD, WEXFORD, PA, UNITED STATES, 15090, Wexford, PA, 15090, USA | Website: https://coeptistx.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE


Market Cap

68.21M

52 Wk Range

$6.26 - $21.41

Previous Close

$13.61

Open

$13.81

Volume

46,402

Day Range

$13.25 - $13.93

Enterprise Value

74.81M

Cash

4.908M

Avg Qtr Burn

-2.152M

Insider Ownership

9.42%

Institutional Own.

9.21%

Qtr Updated

06/30/25